Aisen PS - Search Results

1

Advances in Alzheimer's disease drug development.

Rafii MS, Aisen PS. Rafii MS, et al. Among authors: aisen ps. BMC Med. 2015 Mar 25;13:62. doi: 10.1186/s12916-015-0297-4. BMC Med. 2015. PMID: 25857341 Free PMC article. Review.

2

Recent developments in Alzheimer's disease therapeutics.

Rafii MS, Aisen PS. Rafii MS, et al. Among authors: aisen ps. BMC Med. 2009 Feb 19;7:7. doi: 10.1186/1741-7015-7-7. BMC Med. 2009. PMID: 19228370 Free PMC article. Review.

3

A phase II trial of huperzine A in mild to moderate Alzheimer disease.

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study. Rafii MS, et al. Among authors: aisen ps. Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b. Neurology. 2011. PMID: 21502597 Free PMC article. Clinical Trial.

4

Down's syndrome and Alzheimer's disease: towards secondary prevention.

Ness S, Rafii M, Aisen P, Krams M, Silverman W, Manji H. Ness S, et al. Nat Rev Drug Discov. 2012 Sep;11(9):655-6. doi: 10.1038/nrd3822. Nat Rev Drug Discov. 2012. PMID: 22935789

5

Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.

Rafii MS, Taylor CS, Kim HT, Desikan RS, Fleisher AS, Katibian D, Brewer JB, Dale AM, Aisen PS. Rafii MS, et al. Among authors: aisen ps. Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):159-65. doi: 10.1177/1533317513507373. Epub 2013 Oct 27. Am J Alzheimers Dis Other Demen. 2014. PMID: 24164929 Free PMC article.

6

Effect of TTP488 in patients with mild to moderate Alzheimer's disease.

Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM. Burstein AH, et al. Among authors: aisen ps. BMC Neurol. 2014 Jan 15;14:12. doi: 10.1186/1471-2377-14-12. BMC Neurol. 2014. PMID: 24423155 Free PMC article. Clinical Trial.

7

The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.

Rafii MS, Wishnek H, Brewer JB, Donohue MC, Ness S, Mobley WC, Aisen PS, Rissman RA. Rafii MS, et al. Among authors: aisen ps. Front Behav Neurosci. 2015 Sep 14;9:239. doi: 10.3389/fnbeh.2015.00239. eCollection 2015. Front Behav Neurosci. 2015. PMID: 26441570 Free PMC article.

8

A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study. Relkin NR, et al. Among authors: aisen ps. Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5. Neurology. 2017. PMID: 28381506 Free PMC article. Clinical Trial.

9

EU./U.S. CTAD Task Force on Alzheimer's Trial Populations.

Vellas B, Sampaio C, Bateman R, Boxer A, Carrillo MC, Cummings J, Dubois B, Hampel H, Katz R, Khachaturian Z, Gauthier S, Johnson K, Karlawish J, Mintun M, Petersen R, Rafii M, Robert P, Schneider LS, Siemers E, Sperling R, Tariot P, Touchon J, Weiner M, Andrieu S, Aisen P. Vellas B, et al. J Prev Alzheimers Dis. 2014;1(2):110-116. doi: 10.14283/jpad.2014.6. J Prev Alzheimers Dis. 2014. PMID: 29255837

10

Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.

Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS; AAV2-NGF Study Team. Rafii MS, et al. Among authors: aisen ps. JAMA Neurol. 2018 Jul 1;75(7):834-841. doi: 10.1001/jamaneurol.2018.0233. JAMA Neurol. 2018. PMID: 29582053 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

642 results

Search Page

Filters